EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: From molecular mechanisms to clinical research
Ruifang Dong, Miaolin Zhu, Mingming Liu, Yiting Xu, Liu-Liu Yuan, Jing Bian, Yuan‐Zheng Xia, Lingyi Kong
Topics & Concepts
T790MEpidermal growth factor receptorLung cancerMedicineTargeted therapyCancer researchTyrosine kinaseEGFR inhibitorsOsimertinibMutationDrug resistanceGefitinibErlotinibCancerOncologyBiologyInternal medicineReceptorGeneticsGeneLung Cancer Treatments and MutationsCancer therapeutics and mechanismsColorectal Cancer Treatments and Studies